applicant s thymidylate synthase ts target several anticancer agents due important role de novo synthesis dna need evaluate ts inhibition tissues order assess objectively efficacy ts inhibitors proposal focuses development application vivo positron emission tomography pet evaluate ts inhibition noninvasively tumours normal tissues patients undergoing treatment involves quantitative measurement fractional retention carbon11 labelled thymidine tissues using pet comparisons made direct measurement ts inhibition biopsy specimen imaged tumour also measurement plasma deoxyuridine levels proof principle aim evaluate effect ts inhibitor 5fluorouracil alone combination folinic acid 64 patients entered consolidate facilitate development efficacious ts inhibitors